VANGUARD HEALTH CARE INDEX FUND
VANGUARD WORLD FUND · Series S000004450 · 2 share classes
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2026 Q2
Vanguard Health Care Index Fund (the Fund) seeks to track the performance of a benchmark index that measures the investment return of health care stocks.
The fund tracks the MSCI US Investable Market Index (IMI)/Health Care 25/50 by holding all or substantially all of the stocks in the index in the same proportions, gaining exposure to large, mid-size, and small U.S. health care companies including providers, equipment manufacturers, and pharmaceutical and biotechnology firms. Because the fund attempts to replicate the index rather than sample it, tracking error may arise from the fund's holdings diverging from index weightings.
| Share class | Expense ratio |
|---|---|
| VHCIX | 0.09% |
| VHT | 0.09% |
Portfolio turnover 4.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 99.68% |
| Cash & short-term | 0.19% |
| Derivatives | 0.00% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: MDLN, INDV, DFTX, TLRY, RNA
Largest exited: Avidity Biosciences Inc, Merus NV, Indivior PLC, Akero Therapeutics Inc, Cidara Therapeutics Inc, Avadel Pharmaceuticals PLC, Dynavax Technologies Corp, Mind Medicine MindMed Inc
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| — | — | — | — | — | |
| — | — | — | — | — |
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| LLY | Eli Lilly & CoLLY | 12.54% | $2.54B | 2.4M |
| JNJ | Johnson & JohnsonJNJ | 8.74% | $1.77B | 7.1M |
| ABBV | AbbVie IncABBV | 6.08% | $1.23B | 5.3M |
| MRK | Merck & Co IncMRK | 4.58% | $928.95M | 7.5M |
| UNH | UnitedHealth Group IncUNH | 3.94% | $797.78M | 2.7M |
| AMGN | Amgen IncAMGN | 3.10% | $627.68M | 1.6M |
| ABT | Abbott LaboratoriesABT | 3.00% | $608.24M | 5.2M |
| TMO | Thermo Fisher Scientific IncTMO | 2.92% | $591.05M | 1.1M |
| GILD | Gilead Sciences IncGILD | 2.74% | $555.13M | 3.7M |
| ISRG | Intuitive Surgical IncISRG | 2.67% | $542.17M | 1.1M |
Top 10 positions are 50.31% of net assets, top 25 73.83%, across 411 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free